The closing price of Athira Pharma Inc (NASDAQ: ATHA) was $2.91 for the day, down -18.72% from the previous closing price of $3.58. In other words, the price has decreased by -$0.6700 from its previous closing price. On the day, 1147269 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
Our analysis of ATHA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.37 and its Current Ratio is at 5.37. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
On July 07, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $6.
Stifel Downgraded its Buy to Hold on June 23, 2022, whereas the target price for the stock was revised from $36 to $5.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 05 ’24 when Litton Mark James sold 4,820 shares for $2.91 per share. The transaction valued at 14,026 led to the insider holds 144,397 shares of the business.
Worthington Mark sold 2,412 shares of ATHA for $7,019 on Jan 05 ’24. The General Counsel now owns 34,452 shares after completing the transaction at $2.91 per share. On Jan 05 ’24, another insider, Lenington Rachel, who serves as the Chief Operating Officer of the company, sold 2,412 shares for $2.91 each. As a result, the insider received 7,019 and left with 13,395 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATHA now has a Market Capitalization of 137.21M and an Enterprise Value of -8.62M.
Stock Price History:
Over the past 52 weeks, ATHA has reached a high of $4.30, while it has fallen to a 52-week low of $1.33. The 50-Day Moving Average of the stock is 3.2953, while the 200-Day Moving Average is calculated to be 2.5578.
Shares Statistics:
ATHA traded an average of 387.11K shares per day over the past three months and 486.52k shares per day over the past ten days. A total of 38.17M shares are outstanding, with a floating share count of 35.32M. Insiders hold about 7.84% of the company’s shares, while institutions hold 56.99% stake in the company. Shares short for ATHA as of Feb 15, 2024 were 650.33k with a Short Ratio of 1.68, compared to 513.85k on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.70% and a Short% of Float of 2.33%.
Earnings Estimates
The firm’s stock currently is rated by 4 analysts. On average, analysts expect EPS of -$0.79 for the current quarter, with a high estimate of -$0.73 and a low estimate of -$0.86, while EPS last year was -$0.73. The consensus estimate for the next quarter is -$0.79, with high estimates of -$0.74 and low estimates of -$0.88.
Analysts are recommending an EPS of between -$3.01 and -$3.54 for the fiscal current year, implying an average EPS of -$3.24. EPS for the following year is -$1.97, with 4 analysts recommending between -$0.64 and -$3.58.
